Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1542/peds.2023-064344N | DOI Listing |
J Asthma Allergy
August 2024
BioPharmaceuticals Research and Development, AstraZeneca, Durham, NC, USA.
Purpose: Decentralized clinical trials, where trial-related activities occur at locations other than traditional clinical sites(eg participant homes, local healthcare facilities), have the potential to improve trial access for people for whom time and/or distance constraints may impede participation. Albuterol-budesonide 180/160 µg pressurized metered-dose inhaler (pMDI) is FDA approved for the as-needed treatment or prevention of bronchoconstriction and to reduce the risk of exacerbations in patients with asthma 18 years or older. BATURA (NCT05505734) is a fully decentralized study, investigating as-needed albuterol-budesonide in participants with mild asthma.
View Article and Find Full Text PDFTher Adv Respir Dis
May 2024
BioPharmaceuticals Research and Development, AstraZeneca, Durham, NC, USA.
This summary describes the results of a clinical study called MANDALA that was published in the in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both and in a single inhaler (known as , AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.
View Article and Find Full Text PDFPediatrics
December 2023
La Crosse, WI.
N Engl J Med
August 2022
AstraZeneca, Durham, NC.
N Engl J Med
August 2022
University of Dundee, Dundee, Scotland
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!